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We have successfully synthesized a bivalent hinged molecule that binds metal to undergo 
large conformational changes, similar to an actuator.  Spectrophotometric titrations as 
well as a Job plot have shown that binding occurs on a 1:1 ratio of metal to hinged 
molecule.  Addition of EDTA as a metal scavenger causes the molecule to return to the 
unbound state.  Gel filtration chromatography has shown the effects of metal binding on 
the overall size and shape of the actuator molecule; the “closed” form is much smaller 
than the “open” form, indicating that large conformational changes are occurring upon 
binding.  Analytical ultracentrifugation has unambiguously confirmed that the molecules 
are binding metal in a monomeric fashion.     
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1.0  INTRODUCTION 
Nanoscience is the study of all things on the nanometer scale (in the 1-100 nm range).  It 
encompasses almost all disciplines in science and technology and involves imaging, measuring, 
modeling, and manipulating matter with atomic precision at this small scale. 
Nature is one of the most complex and prolific makers of nano-scale machines.  Billions 
of years of evolutionary feedback have produced extremely sophisticated and efficient biological 
machines.  For example, enzymes have the ability to specifically produce and cleave chemical 
bonds, DNA stores information, and muscles can expand by the action of miniature motors.   
One example of nature’s wonders is the bacterial flagellar motor.1  The flagellar motor is only 50 
nm in diameter, but its spinning can reach speeds on the order of 100 Hz.  With the ability to 
move in any direction, coupled with receptors on the cell’s surface to detect sugars or amino 
acids, cells can move to a more hospitable location.  While the flagellar motor is incredibly 
complex, the basic parts are easier for scientists to emulate.  The ability to create rotors, gears, 
and other basic devices artificially in the lab is the first step toward artificial molecular machines. 
  It is hoped that in the future, nanotechnology will provide pathways to molecular 
fabrication that rival nature in their elegance and efficiency. 
                                                 
1 Berg, H. Annular Review of Biochemistry, 2003, 72, 19-54. 
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1.1 INTRODUCTION TO NANOTECHNOLOGY 
The continued advancement of civilization hinges on our ability to create new and useful 
devices.  In the past few decades, science has focused on making existing devices smaller, 
lighter, and faster.  Some of the biggest advances in nanotechnology have come from the 
semiconductor industry.  The ability to mass-produce improved devices for computers allows for 
more memory to be stored in the same amount of space, making smaller, faster and lighter 
machines possible.  The current norm in manufacturing and miniaturization has been the “top-
down” approach, where small materials are produced from larger structures.  Microchips are 
generally produced using a top-down process known as photolithography2, where a UV light is 
projected through a patterned mask onto a piece of silicon covered with a photosensitive film.  
After the film has been developed, areas that were exposed to light have been removed, and areas 
that were unexposed to light are intact, creating a detailed pattern on the surface of the 
microchip.  Using this method, chips can be made as small as 100 nm; however, continued 
miniaturization will soon encounter the fundamental limitations set by the materials used. 
One of the ways to keep up with this miniaturization trend to make smaller and smaller 
devices is to employ the “bottom-up” approach.  This approach, which was originally proposed 
in 1959 by Richard Feynman3, focuses on creating devices by assembling them one atom or 
                                                 
2 “The History of the Integrated Circuit” www.nobelprize.org 
3 Feynman, R., “There’s Plenty of Room at the Bottom,” a talk at the annual meeting of the American Physical 
Society at CalTech, 12/29/59. 
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molecule at a time.  The most popular of the bottom-up nanotechnology currently being studied 
includes quantum dots and nanotubes. 4,5,6,7 
In the future, it is hoped that nanotechnology will enable the development of nanoscale 
machines capable of systematically manufacturing large-scale atomically precise products 
cheaply and cleanly.  These sorts of developments, as well as the possibilities that we cannot 
predict today, have the ability to improve medicine, the economy, and the environment. 
1.2 NANOTECHNOLOGY AND MOLECULAR MACHINES 
Although traditional synthetic chemistry (the manipulation of single atoms and functional 
groups) is a powerful tool for small molecules, there are many limitations, most notably poor 
overall yields and immense complexity.  In order to produce large and complex nanoscale 
devices, different and more promising approaches need to be explored. 
 Rather than manipulate one atom at a time, supramolecular chemistry explores the 
manipulation of entire molecules.  Supramolecular chemistry is eloquently defined by J.-M. 
Lehn as “the chemistry beyond the molecule, bearing on organized entities of higher complexity 
                                                 
4 Cao, G. Nanostructures & Nanomaterials:  Synthesis, Properties & Applications, Imperial College Press, London, 
2004. 
5 Bowers, M.J.; McBride, J.R.; Rosenthal, S.J. J. Am. Chem. Soc. 2005, 127, 15378 – 15379. 
6 Iijima, S. Nature, 1991, 354, 56-58. 
7 (a) Berber, S.; Kwon, Y.-K.; Tománek, D. Phys. Rev. Lett. 2000, 84, 4613-4616. (b) Kociak, M.; Kasumov, A.Yu.; 
Guéron, S.; Reulet, B.; Khodos, I.I. Gorbatov, Yu.B.; Volkov, V.T.; Vaccarini, L.; Bouchiat, H. Phys. Rev. Lett. 
2001, 86, 2416-2419. 
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that result from the association of two or more chemical species held together by intermolecular 
forces.”8  While traditional organic chemistry involves forming and cleaving covalent bonds, 
supramolecular chemistry makes use of noncovalent interactions, which are much weaker and 
often reversible, including hydrogen bonding, metal coordination, and electrostatic effects to 
assemble molecules into multi-molecular complexes.  
The construction of rotors and other devices is often accomplished using the principles of 
supramolecular chemistry.   Molecular rotors usually involve free rotation around bonds.  One 
such rotor can be found in the metal bis-(porphyrinate) double-decker compounds (Scheme 1).9  
When seen from the top, they can be viewed as two overlapping wheels that rotate about a 
molecular axle.   
 
Low affinity Cooperative      binding
=
=
= Saccharide Guest
OCH3
N
B(OH)2
Br
Free rotation
CeIVCeIV CeIV
 
Scheme 1:  Cooperative binding of saccharides in a molecular rotor. 
 
The porphyrin complex (1) has free rotation, using the cerium bonds as an axle.  
However, as a saccharide guest molecule is bound, a positive allosteric affect induced by the 
                                                 
8 Lehn, J.-M. Angew. Chem. Int. Ed. Engl. 1988, 27, 89. 
9 (a) Tashiro, K.; Konishi, K.; Aida, T. Angew. Chem. Int. Ed. Engl. 1997, 36, 856-858. (b) Shinkai, S.; Ikeda, M.; 
Sugasake, A.; Takeuchi, M. Acc. Chem. Res. 2001, 34, 494-503.  
1
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interaction results, and a loss of rotation occurs, which can be regarded mechanically as a 
“braking” effect. 
Not only can molecular machines be based on rotation about a metal-ligand coordination 
bond like the porphyrin rotor, but they can be based on chemical reactions which produce 
movement.  These include isomerization reactions, acid-base or redox reactions that make or 
break covalent or hydrogen bonds, and metal-ligand reactions that make or break coordination 
bonds.   
A recent and novel molecular device using an isomerization reaction to cause movement 
involves “precipitons” developed by Wilcox.10  These molecules are based upon the structure of 
stilbene, which can exist in two different isomerization forms, cis (2) and trans (3).  Because the 
cis form is much more soluble in a given solvent than the trans form, an isomerization reaction 
can allow for the easy separation of these molecules from a reaction mixture.   
OH
OH
cis
trans
 
Figure 1:  Stilbene-based Precipitons. 
 
                                                 
10 Bosanac, T.; Yang, J.; Wilcox, C.S Agnew. Chem. 2001, 133, 1927-1931.  
2
3
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When relevant functional groups are appended, these precipitons have been proven to 
work as scavengers in copper catalyst removal (Figure 2).11  In this case, UV radiation is the cis 
to trans trigger that causes the metal-precipiton complex to fall out of solution.   
 
Ph
NH
O
N
NH2
NH2
Ph
NH
O
N
NH2
NH2
Cu+ Cu+
Ph
NH
O
N
NH2
NH2
Cu+
hν
(Xenon Arc Lamp)
Solid  
Figure 2:  Metal-scavenging precipitons. 
 
A few systems that use acid-base reactions to produce movement are [2]rotaxanes and 
catenanes.  In these cases, while the two components are not linked covalently, they cannot 
dissociate from one another either.  Their molecular motions are based upon either the rotation of 
the macrocycles, or the movement of the macrocycle from one site to another on the dumbbell-
shaped molecules (Figure 3).  By controlling the movement of the macrocycles, with either 
hydrogen- or metal-binding sites, they can function as molecular switches or shuttles with 
potential uses in molecular electronics as logic switching elements.12   
                                                 
11 Honigfort, M.; Brittain, W. J.; Bosanac, T.; Wilcox, C. S. Macromolecules 2002, 35, 4849. 
12 Sauvage, J.-P. Acc. Chem. Res. 1998; 31, 611-619. 
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Figure 3:  Schematic representation of the possible motions of rotaxanes and catenanes. 
 One of the most famous examples of rotaxanes as molecular devices is J.F. Stoddart’s 
molecular elevator.13  By using an interlocked three rotaxane system with different recognition 
sites and a three-ring macrocycle with different affinities for each recognition site, a stable, 
multivalent elevator was created.  It was synthesized by threading the macrocyclic system (4) 
onto the rotaxane center (5), followed by stoppering the open ends (6) to lock the ring 
mechanically into place (Scheme 2).  The ring system can be moved from one site to the other by 
the addition of acid or base.   
                                                 
13 (a) Badjic, J.D.; Balzani, V.; Credi, A.; Stoddart, J.F. Science 2004, 303, 1845-1849. (b) Badjic, J.D.; Ronconi, 
C.M.; Stoddart, J.F.; Balzani, V.; Silvi, S.; Credi, A. J. Am. Chem. Soc. 2006, 128, 1489-1499. 
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Scheme 2:  Molecular elevator synthesis. 
 
Although the most complex molecular machines being studied today are not on the level 
of those made by nature, the ability to understand and mimic nature is the first step toward 
creating synthetic devices that can compete side-by-side with those made by nature.   
4
5
6
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1.3 FOLDAMERS AND THE ROLE OF BIS-AMINO ACIDS 
The functionality exhibited by proteins in nature is based on their three-dimensional 
structures.  Something that has long eluded biochemists is the ability to predict how a protein can 
reliably fold from a primary sequence of amino acids monomers into a single, stable tertiary 
structure despite almost infinite possibilities.  The folding is directed by various interactions such 
as hydrogen bonding, van der Waals forces, and dipole interactions, the combination of which 
has so far been impossible to predict for an artificial biomolecule.  This is known as the protein-
folding problem and it has obstructed the creation of useful synthetic proteins. 
Foldamers are one way scientists are trying to get around the protein folding problem.  
Foldamers are a class of unnatural oligomers that mimic proteins and other biomolecules by 
folding into well-defined secondary structures using only non-covalent interactions such as 
hydrogen bonding, π-stacking, etc.   
Foldamers have demonstrated the ability to perform many functions, including self-
assembly, host-guest chemistry, and molecular recognition.14  They are a useful alternative to 
supramolecular assemblies due to their versatility and ease of construction from monomers.   
Several examples of monomers that have been used in foldamers are shown in Figure 4.15 
                                                 
14 Hill, D.J.; Mio, M.J.;  Prince, R.B.; Hughes, T.S.; Moore, J.S. Chem. Rev. 2001, 101, 3893-4011. 
15 (a) Seebach, D.; Abele, S.; Sifferlen, T.; Hänggi, M.; Gruner, S.; Seiler, P. Helv. Chim. Acta 1998, 81, 2218-2243. 
(b) Appella, D.H., Barchi, J.J.; Durell, S.R.; Gellman, S.H. J. Am. Chem. Soc. 1999, 121, 2309-2310. (c) 
Kirshenbaum, K.; Barron, A.E.; Goldsmith, R.A.; Armand, P.; Bradley, E.K.; Troung, K.T.V.; Dill, K.A.; Cohen, 
F.E.; Zuckermann, R.N. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 4303-4308. (d) Claridge, T.D.W., Long, D.D.; 
Hungerford, N.L.; Aplin, R.T.; Smith, M.D.; Marquess, D.G.; Fleet, G.W.J. Tetrahedron Lett. 1999, 40, 2199-2202. 
(e) Smith, A.B.; Guzman, M.C.; Sprengeler, P.A.; Keenan, T.P.; Holcomb, R.C.; Wood, J.L.; Carroll, P.J.; 
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Figure 4:  Examples of current foldamers. 
 
One example uses Moore’s water-soluble m-phenylene ethynylene monomer (Figure 5).16  
The use of hexaethylene glycol side chains increases solubility of the foldamer and the 
hydrophobic interior creates a pocket in which small molecules can bind.  Seen below in Figure 
5 is the binding of the foldamer with (-) α-pinene. 
*
*
O O
O
*
6
n  
Figure 5:  The monomer used;  The binding of a small molecule in the foldamer. 
 
                                                                                                                                                             
Hirschmann, R. J. Am. Chem. Soc. 1994, 116, 9947-9962. (f) Gude, M.; Piarulli, U.; Potenza, D.; Salom, B.; 
Gennari, C., Tetrahedron Lett. 1996, 37, 8589-8592. (g) Hamuro, Y.; Geib, S.J.; Hamilton, A.D. J. Am. Chem. Soc. 
1996, 118, 7529-7541. 
16 Stone, M.T.; Moore, J.S. Org. Lett. 2004, 6, 469-472. 
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Another approach to biomimetic molecules pioneered by the Schafmeister group17 is the 
use of bis-amino acids as monomers in the synthesis of water-soluble oligomers.  These bis-
amino acids couple to each other through pairs of amide bonds to form spiro-ladder oligomers 
(Figure 6).  These oligomers do not fold, rather they display complex shapes due the 
conformational preferences of the fused ring systems as well as the inherent stereochemistry of 
the monomers. 
Boc
NHO2C
NHFmoc
MeO2C
N
HN N
HN
O
OO
O
A monomer by itself... An oligomer connected throughdiketopiperazine linkages.  
Figure 6:  A monomer & its corresponding fused ring system counterpart. 
 
The continuing goal of our group is to be able to create functional oligomers by 
programming a specific sequence from our current library of monomers to create different three-
dimensional shapes (Figure 7). 
                                                 
17 (a) Levins, C.G.; Schafmeister, C.E. J. Am. Chem. Soc. 2003, 125, 4702-4703. (b) Habay, S.A,; Schafmeister, 
C.E. Org. Lett. 2004, 6, 3369-3371. (c) Gupta, S.; Das, B.C.; Schafmeister, C.E. Org. Lett. 2005, 7, 2861-2864. (d) 
Levins, C.G.; Schafmeister, C.E. J. Org. Chem. 2005, 70, 9002-9008. (e) Levins, C.G.; Brown, Z.Z.; Schafmeister, 
C.E. Org. Lett. 2006, 8, 2807-2810. 
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Fmoc FmocFmocFmoc
Fmoc Fmoc Fmoc Fmoc
 
Figure 7:  The library of monomers and a representation of possible complex shapes. 
 
 As we are still working toward this goal of creating complex shapes and functionalities, 
we seek to use our most common monomer, the pro4(2S4S) monomer, to create a basic 
molecular machine.  An oligomer consisting of consecutive pro4(2S4S) monomers coupled 
together creates a simple rod.18  We want to use simple components:  two rods, a hinge, and 
metal-binding receptors, to create something more complex, a molecular device. 
                                                 
18 Levins, C.G.; Schafmeister, C.E. J. Am. Chem. Soc. 2003, 125, 4702-4703. 
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2.0  MOLECULAR ACTUATORS CONTROLLED BY METAL BINDING 
We seek to develop a molecular machine that can exist in two different states, and with the 
ability to move payloads long distances, i.e. ~3 nm, using a single variable – the presence or 
absence of metal.  A system such as this is known as an actuator: a device that transforms an 
input signal into motion. 
With this in mind, we utilized 8-hydroxyquinoline (Q) in our bis-amino acid oligomer 
system.  We created an oligomer with a rod-hinge-rod assembly that can display different 
payloads on either side, and placed a Q at each end as a metal binding group (see Figure 8).   
 
 
Figure 8:  Molecular actuator in open and closed states. 
 
In the absence of metal, the oligomer should be extended and floppy  (the “open” state) due to 
the rotatable bonds in the hinge, with an extended length of up to 5 nm.  When metal is 
introduced however, we believe that the oligomer folds up into the “closed” state (~2.5 nm by ~1 
  14
to 2 nm), forming a 1:1 monomeric complex with the metal.  With this system, in addition to the 
open/closed state we desire, there is also the possibility of dimerization, trimerization, etc. as 
well as aggregation of our oligomers in the presence of metal (Figure 9). 
 
Figure 9:  Possible bound conformations of the actuators:  monomers, dimers, oligomers. 
 
To characterize our assemblies, we have used UV/Vis spectroscopy, size-exclusion 
chromatography, and analytical centrifugation.  Low solubility of these complexes in the 
presence of metals impeded our ability to study them using NMR. 
  15
2.1 8-HYDROXYQUINOLINE AS A MODEL SYSTEM 
In order to study the binding and structural properties of our actuator, we decided to incorporate 
as the binding group an 8-hydroxyquinoline (Q) derivative.  Its square planar structure19 as well 
as its binding properties to various metals have been studied extensively, with copper being one 
of the most stable metals in the Mellor and Maley chelate stability series. 20   The overall 
association constant for copper binding to Q [Q2Cu] has been found to be approximately K = 
8×1024 M-2,21 which corresponds to a favorable free energy of ~33 kcal/mol at 25 ºC.  When this 
is shown in comparison to a typical carbon-hydrogen bond strength of 81 kcal/mol,22 it is seen 
that the 8-hydroxyquinoline [Q2:Cu] system is extremely tight binding.  As a synthetic complex, 
8-hydroxyquinoline is commonly used as a binding or molecular recognition tool.23   
                                                 
19 (a) Bevan, J.A.; Graddon, D.P.; McConnell, J.F. Nature (London) 1963, 199, 373. (b) Murray-Rust, P.; Wright, 
J.D. Inorg. Phys. Theor. 1968, 247-253. (c) Hoy, R.C.; Morriss, R.H.; Acta Crystallogr. 1967, 22, 476-482. 
20 (a) Schulman, S.G.; Gershon, H. J. Inorg. Nucl. Chem. 1969, 31, 2467-2476. (b) Näsänen, R.; Penttinen, U. Acta 
Chem. Scand. 1952, 6, 837-843. (c) Richard, C.F.; Gustafson, R.L.; Martell, A.E. J. Am. Chem. Soc. 1959, 81, 1033-
1040. (d) Mellor, D.P.; Maley, L.E. Australian J. Sci. Research 1949, 2A, 92-110. 
21 Albert, A. Biochem. J. 1953, 54, 646-654. 
22 Huber, K.P; Herzberg, G., Molecular Spectra and Molecular Structure Constants of Diatomic Molecules, Van 
Nostrand, New York, 1979. 
23 (a) Watson, R.M.; Skorik, Y.A. Patra, G.K.; Achim, C. J. Am. Chem. Soc. 2005, 127, 14628-14639. (b)  Asher, 
S.A.; Sharma, A.C.; Goponenko, A.V.; Ward, M.M. Anal. Chem. 2003, 75, 1676-1683. 
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N
OH
N
O
N
O
M
M2+
2
 
Figure 10:  8-hydroxyquinoline in its free and bound forms. 
 
In order to attach it to our scaffolds as well as due to its low solubility in water, we 
decided to convert 8-hydroxyquinoline into the more soluble 8-hydroxyquinolyl acetic acid (QA) 
derivative.  This also allowed us to incorporate the binding group into our oligomers using solid 
phase synthesis.  It was prepared as seen in Scheme 3, using literature procedures.24 
 
N
OH N
OH
O
HO
(a) HCl, formaldehyde
(b) NaCN, DMSO, 90 °C
(c) HCl
 
Scheme 3:  Synthesis of 8-hydroxyquinolyl acetic acid. 
 
 In the UV-Vis absorption spectra of QA in pH 7.0 sodium phosphate buffer, the two 
strong absorption bands at 244 nm and 259 nm stand out strongly in the absence and presence of 
metal respectively.  Weakly absorbing peaks are seen at 320 nm and 385 nm.  Addition of metal 
causes absorption bands to red shift from 244 nm to 259 nm and 320 to 385 nm, demonstrating 
that metal binding to QA is occurring (Figure 11).   
                                                 
24 (a) Burckhalter, J.H.; Leib, R.I. J. Org. Chem. 1961, 26, 4078-4083. (b) Warner, V.D.; Sane, J.N.; Mirth, D.B.; 
Turesky, S.S.; Soloway, B.  J. Med. Chem. 1976, 19, 167-169. 
Q QA
  17
 
Figure 11:  UV/Vis absorption, blue - unbound QA, red - QA bound to Cu. 
 
A titration was performed using 22 μM QA by addition of small aliquots of 380 μM 
CuCl2 in pH 7.0 phosphate buffer.  The titration curves show an inflection point at Cu2+:QA of 
~1:2.  Isosbestic points are observed at 251 nm and 346 nm, suggesting a direct conversion of 
one species to another, QA ? [QA2:Cu] – 2:1 binding (Figure 12).  Further addition of Cu2+ 
shows no other inflection points, indicating that once the 2:1 complex forms, it cannot be 
converted by excess Cu2+ to 1:1 complexes (Figure 13). 
 
 
  18
 
Figure 12:  Spectrophotometric titration of a 22 μM solution of QA (10 mM sodium phosphate buffer, 
pH 7.0, T = 25 ºC) with a 380 μM solution of CuCl2.  The arrows indicate the direction of change in 
absorbance with increasing copper concentration. 
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Figure 13:  Spectrophotometric titration of QA, monitored at 244 nm and 259 nm (22 μM solution of 
QA, 10 mM sodium phosphate buffer, pH 7.0, T = 25 ºC, titrated with 380 μM CuCl2). 
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2.2 ACTUATOR SYNTHESIS 
Our initial design of the actuator had rods comprising of 4 building blocks, an (L)-ornithine 
hinge, and a napthylalanine chromophore: 7.   
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Figure 14:  Scaffold structure of actuator 7. 
Scaffold 7 was made using standard Fmoc solid phase peptide synthesis techniques.  
Fmoc-(L)-1-Napthylalanine, which provides a UV chromophore, was coupled initially (using 
MSNT and methyl imidazole) to the hydroxymethyl resin (8).  An ivDde-protected 
diaminobutanoic acid group was coupled next using the standard HATU / DIPEA conditions to 
give compound 9.  This was followed by the coupling of four consecutive pro4(2S4S) monomers 
to form the first “rod” section of the actuator (10). 
7
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Scheme 4:  Solid phase synthesis of scaffold 7. 
 
Next, an Mtt-protected (L)-ornithine was attached for the “hinge” portion.  Mtt 
deprotection, which does not remove the ivDde protected amine at the beginning of the rod, 
followed by another coupling of four consecutive pro4(2S4S) monomers formed the second 
“rod” section of the actuator (12). 
1.  Fmoc-(L)Ornithine(Mtt),
     HATU, DIPEA
2.  20% piperidine / DMF, 2h
3.  1% TFA, 5% TIS, DCM
1.  Fmoc-Pro4(2S4S),
     HATU, DIPEA
2.  20% piperidine / DMF
4
O
O HN
O
NH
O
N
H
O
(ivDde)HN
N
NH
O
O OMe
Boc
N
NH
O
O OMe
Boc
N
NH
O
O OMe
Boc
N
Boc
N
H
H
NO
O
N NH
O
O
OMe
Boc
N NH
O
O
OMe
Boc
N NH
O
O
OMe
Boc
N
Boc
NH2
O
OMe
O
O H
N
O
N
H
O
NH2
(ivDde)HN
N
NH
O
O
OMe
Boc
N
NH
O
O
OMe
Boc
N
NH
O
O
OMe
Boc
N
Boc
N
H
H
NO
O
 
Scheme 5:  Solid phase synthesis of scaffold 7. 
Coupling of an Mtt-protected diaminopropionic acid followed by Mtt deprotection gave a 
free amine at the end of the scaffold.  If another payload was desired at this end of the scaffold, 
8
9
10
11
12
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modifications at this point would be made for its inclusion.   No end payload was required, so an 
ivDde deprotection allowed for the opening of the site at beginning of the molecule so the 
receptor can be coupled to both sites (13).  Quadruple couplings with short 20% piperidine/DMF 
washings after each coupling, allowed for complete conversion to compound 14, while 
preventing polymerization of QA.   
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Scheme 6:  Solid phase synthesis of scaffold 7. 
 
 Cleavage of the oligomer from the resin using standard triflic acid method was followed 
by base-catalyzed diketopiperazine (DKP) closure to give the final rigidified scaffold, 7. 
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Scheme 7:  Cleavage and DKP closure of scaffold 7. 
2.3 RESULTS & DISCUSSION 
The stoichiometry of Cu2+ binding to actuator 7 was studied by performing titrations and 
monitoring absorbance changes to the relevant wavelengths.  A solution of scaffold 7 with a 
concentration of 17 μM  was titrated with 150 μM CuCl2 at room temperature (Figure 15). 
 
7
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Figure 15:  Spectrophotometric titration of a 17 μM solution of scaffold 7 (10 mM sodium phosphate 
buffer, pH 7.0, T = 25 ºC) with a 150 μM solution of CuCl2.  The arrows indicate the direction of change in 
absorbance with increasing copper concentration. 
Isosbestic points are observed at 251 nm and 346 nm, suggesting a direct conversion of 
one species to another, 7 to [7:Cu] – 1:1 binding.  The UV-Vis titration curves at 244 and 259 
nm show an inflection point at Cu2+:7 of ~1:1.  Further addition of Cu2+ shows no other 
inflection points, implying no formation of 1:2 (7:Cu2) complexes (Figure 16).   
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Figure 16:  Spectrophotometric titration of 7 monitored at 244 nm and 259 nm (17 μM solution of 7, 
10 mM sodium phosphate buffer, pH 7.0, T = 25 ºC, titrated with 150 μM CuCl2). 
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Scaffold 7 was also titrated using other metals including NiCl2, CoCl2, ZnBr2 with similar 
results to CuCl2. 
In addition to titrations, a Job plot experiment (Figure 17) was performed to confirm the 
stoichiometry of copper bound scaffold 7.  
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Figure 17:  Job plot of scaffold 7 & CuCl2. 
As seen above, the Job plot shows a maximum at a mole fraction of approximately 0.52 
indicating a 1:1 ratio of scaffold 7 to Cu2+, confirming the stoichiometry findings from the 
copper titration. 
The reversibility of the Cu2+ binding to scaffold 7 was studied using EDTA 
(ethylenediaminetetraacetic acid) as a copper scavenger.  To a 27 μM solution of scaffold 7 at 
room temperature (a) was added 1 eq. CuCl2 to fully bind all binding sites (b).  Three equivalents 
EDTA was then added to scavenge the copper in solution.  As seen in Figure 18, approximately 
90-95% of scaffold 7 was returned to the unbound state with a λmax of 244 nm (c). 
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Figure 18:  The reversibility of Actuator 7:  (a) actuator sample with no metal present, (b) sample 
with one equivalent of CuCl2 present, (c) sample after metal has been scavenged. 
A hinge-less control molecule consisting of an 8 building block length rod, 15, was 
synthesized and tested 25  to determine the stoichiometry of this molecule when monomeric 
actuation is impossible (Figure 19). 
                                                 
25 Thanks to Sam Getchell for the synthesis and titration of molecule 15. 
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Figure 19:  Scaffold 15. 
UV/Vis experiments of this bivalent molecular rod were carried out by titrating a solution of 104 
μM CuCl2 into 18 μM 15 in a 7 mM pH 7.0 ammonium acetate / 30% acetonitrile solution 
(scaffold 15 was found to have poor solubility in phosphate buffer).  As with scaffold 7, the 
unbound state has peaks at 244 nm and 315 nm, characteristic of unbound QA (Figure 20).  As 
metal is titrated in, peaks at 259 nm and 385 nm begin to appear, but then immediately disappear 
as more metal is added.  This is also accompanied by a slight cloudiness to the titration solution.  
We believe that this indicates the molecule is binding metal and coordination polymers are 
forming which are so large that they precipitate out of solution. 
15
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Figure 20:  Spectrophotometric titration of an 18 μM solution of 15 (7 mM pH 7.0 ammonium acetate 
/ 30% acetonitrile buffer solution, pH 7.2, T = 25 ºC) with 104 μM CuCl2.  Inset are the corrected titration 
curves, monitored at 244 nm and 259 nm. 
Gel filtration chromatography (also known as size exclusion chromatography) is a 
technique in which compounds are separated based on their size rather than affinity with the 
column matrix.  The column matrix is a composite of cross-linked agarose and dextran, a porous 
media in the form of spherical particles.  As the buffer and sample move through the column, 
molecules diffuse in and out of the pores of the column matrix.  Small molecules can diffuse 
further into the pores and migrate slowly, while molecules that are larger than the pores of the 
matrix cannot interact in this manner and therefore pass through the column more quickly.   
In our studies, we are attempting to determine the relative sizes of the bound and 
unbound scaffolds.  If the bound form elutes before the unbound form, then it is likely that the 
bound form is of a larger size and consists of dimers, trimers, or oligomers.  If the bound form 
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elutes after the unbound form however, then it can be considered smaller than the actuator in its 
open form, and the actuator is most likely closing up into the monomer form.   
The molecule used for the gel filtration study was scaffold 7, and the gel filtration 
chromatograms are shown below.  The eluent used was 7 mM pH 7.2 ammonium acetate buffer 
with 30% acetonitrile.  While every effort was made to ensure that with the choice of eluent there 
would be no interactions with the column matrix, we discovered that the column has slight ion 
exchange capability.  We therefore washed the column with a 7 mM pH 7.0 EDTA solution 
containing 30% acetonitrile to remove residual metals before the injection of the unbound 
actuator and then with a 7 mM pH 7.2 ammonium acetate buffer with 30% acetonitrile and 100 
μM CuCl2 to fill up the column’s metal-chelating sites before the injection of the bound actuator.  
This ensured that the unbound actuator would not pick up any metal while in the column and the 
bound actuator would not lose any metal. 
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Figure 21:  Size exclusion chromatograms of 7 in the metal free state (blue, monitored at 244 nm) and 
in the presence of one equivalent of CuCl2 (red, monitored at 259 nm). 
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As seen in Figure 21, the unbound actuator elutes at 34.3 minutes and the copper bound 
actuator elutes at 37.8 minutes.  The metal free vs. metal bound state was determined by 
measuring the absorption of the peaks (Figure 22).   
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Figure 22:  Absorbance spectra of the size exclusion chromatogram peaks of 7, confirming the metal 
free (34.3 min) and the metal bound (37.8 min) states. 
 
The positive elution time difference confirms that the size of the actuator is in fact 
decreasing slightly, which supports our hypothesis that the molecule is closing as a monomer 
rather than in dimers or other higher order structures with the addition of metal.  The scale of the 
time difference, +3.5 minutes, shows how the simple act of binding can greatly affect the overall 
size and shape of the molecule.   
Analytical ultracentrifugation, a classical technique that allows for the measure of 
molecular weight in solution, is another experiment that can confirm the monomeric nature of 
the bound actuator.  Two types of ultracentrifugation experiments are available:  sedimentation 
velocity, the application of a high centrifugal force and analysis of the time-course of the 
sedimentation process, and sedimentation equilibrium, the application of low centrifugal force 
that permits diffusion to balance sedimentation to allow observation of an equilibrium gradient.   
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 A sedimentation equilibrium experiment was performed on both metal free and copper 
bound samples in 10 mM pH 7.0 phosphate buffer.  Using an estimated partial specific volume 
( v  = 0.73 mL/g, standard for proteins), the molar mass, M, was determined using the equation 
below:26 
 
Two samples of scaffold 7, metal free at 7 μM, and copper bound at 5 μM were spun at 
60,000 rpm for > 8 h before equilibrium was observed.  The absorbance curve (measured at 244 
and 255 nm, respectively) from the metal free and metal bound samples are shown below. 
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Figure 23:  Absorbance curves within the sample cells of 7, in the metal free state and in the presence 
of metal. 
 
 Using the above equation, the molar mass of the metal free was found to be 2400 Da, and 
the molar mass of the metal bound was found to be 2700 Da.  While the mass is 20-30% larger 
than what is expected from the sequence (1990 Da metal free, 2051 Da metal bound), this is 
                                                 
26 Wills, P.R.; Winzor, D.J. Prog. Colloid Polymer Sci. 2001, 119, 113-120. 
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most likely due to the estimation of v .  The fact that the masses of the metal free and metal 
bound samples are close to each other implies that the molecule is a monomer in the metal free 
and metal bound states. 
2.4 CONCLUSIONS 
We have successfully synthesized a bivalent hinged molecule that binds metal to undergo large 
conformational changes, similar to an actuator.  Spectrophotometric titrations as well as a Job 
plot have shown that binding occurs on a 1:1 ratio of metal to hinged molecule.  Addition of 
EDTA as a metal scavenger causes the molecule to return to the unbound state.  Gel filtration 
chromatography has shown the effects of metal binding on the overall size and shape of the 
actuator molecule; the “closed” form is much smaller than the “open” form, indicating that large 
conformational changes are occurring upon binding.  Analytical ultracentrifugation has also 
unambiguously confirmed that the molecules are binding metal in a monomeric fashion.    These 
results are a first step toward metal-sensing nanovalves and other storage-release type 
nanosystems. 
Another method planned to study the open and closed states of our actuators is to use 2-D 
electron spin resonance.  This technique is capable of measuring exact distances between two 
unpaired electrons, placed at either end of a molecule.  By measuring these large distances, the 
overall shape of the compound can be inferred.   
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3.0  EXPERIMENTAL 
3.1 GENERAL 
Solid phase synthesis was performed in disposable polypropylene reaction columns, connected to 
a three-way valve equipped with vacuum and argon for mixing.  The dichloromethane (DCM) 
used in coupling reactions was distilled over calcium hydride.  The dry grade 
dimethylformamide (DMF) used in coupling reactions was purchased from Aldrich.  
Diisopropylethylamine (DIPEA) was distilled under nitrogen sequentially from ninhydrin and 
potassium hydroxide and stored under molecular sieves.  O-(7-Azabenzotriazon-1-yl)-N,N,N’,N’-
tetramethyluronium hexafluorphosphate (HATU) was obtained from GenScript.  8-
Hydroxyquinoline was obtained from Aldrich.  All amino acids and resins were obtained from 
Novabiochem unless otherwise noted.  Pro4(2S4S) monomer was synthesized using literature 
procedures.17  All solid phase reactions were mixed by bubbling argon up through the reactor, 
allowing for mixing and an inert atmosphere over the reaction.   
HPLC-MS analysis was performed on a Hewlett-Packard 1050 HPLC / 1100 electrospray 
MS instrument equipped with a Waters Xterra MS C18 column (3.5 μm packing, 4.6 mm x 100 
mm) and a diode-array detector.  High resolution ESI-MS was performed on a Waters LC/Q-
TOF instrument.  Preparative HPLC was performed on a Varian ProStar 500 HPLC system with 
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an XTerra Prep MS C18 column (5 μm packing, 30 mm x 100 mm).  UV-Vis experiments were 
performed on a Varian Cary 50 Bio spectrophotometer in 10 mm quartz cells.   
Gel filtration chromatography was performed on a Hewlett-Packard 1050 HPLC 
instrument equipped with a Superdex Peptide 10/300 GL column (13 μm packing, 10 mm x 300-
310 mm).   
Analytical ultracentrifugation was performed on a Beckman Optima XL-A / XL-I 
analytical ultracentrifuge.  Data was analyzed using the SEDFIT27 and SEDNTERP28 programs. 
The concentrations of all solutions of molecules containing Q were determined by UV 
absorption at 25 ºC using the extinction coefficient є244 or є259 (2 x є244 = 56,100 L mol-1 cm-1, 
є259 = 49400 L mol-1 cm-1 determined at pH 7.0 from the slope of the calibration curve Aλ versus 
concentration).  All solutions for Job plots and titrations had concentrations in the micromolar 
range (10-50 μM) and were prepared in pH 7.0 10 mM phosphate buffer.  UV-Vis titrations were 
carried out by addition of standard metal solutions in water to the titration solution.  The 
absorbance spectra were corrected for dilution and for the absorbance of the metal. 
 
 
 
                                                 
27 SEDFIT, <http://www.analyticalultracentrifugation.com/default.htm> 
28 SEDNTERP, <http://www.jphilo.mailway.com/download.htm> 
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3.2 ACTUATOR SYNTHESES 
General Solid Phase Peptide Synthesis Procedures: 
General Procedure A (HATU coupling): 
In a microcentrifuge tube, the amino acid (2 equiv) was dissolved in 20% DCM/DMF 
(0.2 M) with HATU (2 equiv).  After mixing, DIPEA (5 equiv) was added.  The solution was left 
to sit for 10 min activation time, and it was then added to the resin and allowed to react under 
argon bubbling for 30 min followed by washing with 2 mL each of DCM, i-PrOH, DCM for 2 
min under argon bubbling.  This coupling and washing step was repeated one additional time 
with the same amino acid.   
General Procedure B (Capping): 
Unreacted amines are capped by addition of 1 mL of a solution of 50:12.5:1 DMF/Acetic 
Anhydride/DIPEA with argon bubbling for 20 minutes followed by thorough washing with 2 mL 
each of DMF, i-PrOH, DMF for 2 min under argon bubbling. 
General Procedure C (Fmoc Deprotection): 
Deprotection of the Fmoc-protected amine is performed by addition of 1 mL of 20% 
piperidine/DMF followed by argon bubbling for 30 min.  The coupling yield can be determined 
by measuring the absorbance of the piperidine/dibenzofulvene adduct (ε301 = 7800 M-1 cm-1) in 
this solution.  The resin is then washed thoroughly with 2 mL each of DMF, i-PrOH, DMF, i-
PrOH, and DMF for 2 min each under argon bubbling.   
 
Synthesis of 7: 
A 50 mg batch of hydroxymethyl polystyrene (100-200 mesh) resin (0.98 mmol/g 
substitution) was transferred to a solid phase reaction vessel.  The resin was swollen and the first 
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amino acid, 42.9 mg N-Fmoc-1-napthyl-L-alanine (Acros, 98 μmol), was added to a solution of 
1-(mesitylene-2-sulfonyl)-3-nitro-1H-1,2,4-triazole (MSNT), and 1-methylimidazole (MeIm) in 
DCM and mixed using a micropipettor in a 1.5 mL microcentrifuge tube (5 eq. Amino acid, 5 eq. 
MSNT, 3.75 eq. MeIm, 0.2 M amino acid in DCM).  This solution was added to the resin and 
allowed to react under argon bubbling for 1 h followed by washing with 2 mL each of DCM, i-
PrOH, DCM for 2 min under argon bubbling.  This coupling and washing step was repeated one 
additional time with the same amino acid.  The sequence was then capped using general 
procedure B and deprotected using general procedure C. 
Nα-Fmoc-Nγ-ivDde-L-diaminobutanoic acid (21.4 mg, 39.2 μmol) was coupled to the 
resin using the general procedure A, and the sequence was capped using general procedure B and 
deprotected using general procedure C. 
Nα-Fmoc-Nβ-Boc pro4(2S4S) was coupled to the resin using general procedure A.  After 
capping using general procedure B and deprotection using general procedure C, these steps were 
repeated three more times for this residue, pro4(2S4S), to give a total of 4 identical residues in a 
row.   
Nα-Fmoc-Nδ-Mtt-L-ornithine (23.9 mg, 39.2 μmol) was coupled to the resin using general 
procedure A and capped using general procedure B.  The deprotection step (general procedure C) 
however was extended to a total of 2 h to allow for complete diketopiperazine formation.  
Capping using general procedure B was then repeated, followed by a deprotection of the Mtt 
group using 1% TFA and 5% TIS in DCM, 10 × 1 mL under argon bubbling.  The resin was then 
neutralized using 5% DIPEA/DCM, 2 × 1 mL under argon bubbling.   
Nα-Fmoc-Nβ-Boc pro4(2S4S) was coupled to the resin using the general procedure A.  
After capping using general procedure B and deprotection using general procedure B, these steps 
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were repeated three more times for this residue, pro4(2S4S), to give a total of 4 identical residues 
in a row.   
Nα-Fmoc-Nε-Mtt-L-diaminopropionic acid (22.8 mg, 39.2 μmol) was coupled to the resin 
using general procedure A and capped using general procedure B.  The deprotection step 
(general procedure C) was performed for a total of 2 h to allow for complete diketopiperazine 
formation.  The capping step was then repeated, followed by a deprotection of the Mtt group 
using 1% TFA and 5% TIS in DCM, 10 × 1 mL under argon bubbling.  The resin was then 
neutralized using 5% DIPEA/DCM, 2 × 1 mL under argon bubbling.  The N-ivDde protecting 
group on the second residue was then removed using 2% hydrazine in DMF, 10 x 1 mL under 
argon bubbling.  The resin was then washed with 2 mL each of DMF, i-PrOH, DMF, i-PrOH, 
and DMF for 2 min each under argon bubbling.   
5-Carboxymethyl-8-hydroxyquinoline (19.9 mg, 98 μmol) was coupled using general 
procedure A, however using 5 equiv acid, 4.8 equiv HATU, 10 equiv DIPEA, 0.2 M in 20% 
DCM/DMF.  The resin was washed with 1 mL of 20% piperidine/DMF under argon bubbling to 
break up any 8-hydroxyquinoline phenyl ester polymeric chains that had formed on the resin.  
This coupling and washing step was repeated three additional times.  The resin was then 
prepared for cleavage by washing with 2 mL each of DMF, i-PrOH, DMF, i-PrOH, DCM, 
MeOH, DCM, MeOH, and DCM for 2 min.  The reactor was then put in a vacuum tube, and 
dried under reduced pressure overnight.   
A small stir bar was added to the solid phase reaction vessel, which was then capped and 
submerged in an ice bath.  Ethanedithiol (12.5 μL) and thioanisole (25 μL) were added followed 
by TFA (250 μL) and triflic acid (25 μL).  The cleavage solution was stirred for 1 h at 0 ˚C and 1 
h at room temperature and then filtered dropwise to room temperature ether (15 mL).  The resin 
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was washed with TFA, which was filtered into ether as well.  The resulting precipitate was 
pelleted by centrifugation.  The pellet was washed again with ether and dried to a yellow residue 
using lyophilization.  This residue was then dissolved in 20% piperidine/NMP (2 mL) and sealed 
in an HPLC vial for 36 h with diketopiperazine closure monitored by LCMS.  This solution was 
then added dropwise to ether, and the precipitate was pelleted by centrifugation.  The product 
was purified by preparative HPLC (mobile phase, MeCN (0.05% formic acid) / H2O (0.1% 
formic acid), 0% to 50% MeCN over 30 minutes; flow rate 25 mL/min).  Desired fractions were 
concentrated by lyophilization to give a fluffy light yellow solid.  The expected mass of 7 was 
confirmed by HPLC-MS, illustrated in Figure 24 and Figure 25, as well as by high resolution 
electrospray mass spectrometry (Figure 26-30).  The double, triple and quadruple charged 
species were observed. [HR-MS (ESI) calculated for C95H101N23O25 (M+2H)/2: 995.8700, found 
995.9069; (M+3H)/3: 664.2493, found 664.2669; (M+4)/4: 498.4389, found 498.4535]. 
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Figure 24:  HPLC chromatogram of 7: mobile phase, H2O (0.1% formic acid) / CH3CN, 5% to 50% 
CH3CN over 30 min; flow rate, 0.80 mL/min; UV detection at 254 nm; tR for 7, 12.1 min. 
 
Figure 25:  Low resolution mass trace of 7; ESI-MS m/z (ion) 995.6 (M + 2H+)/2, 664.3 (M + 3H+)/3, 
498.6 (M + 4H+)/4.  
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Table 1:  Calculated and observed m/z values of 7.  Calculation of deviation in ppm between 
calculated and experimental m/z. 
Mass of H 1.0078    
 
Calculated 
m/z 
Experimental 
m/z delta M 
Calculation of 
deviation 
M 1989.7244    
(M+1)/1 1990.7322    
(M+2H)/2 995.87002 995.9069 0.0369 7.56 ppm 
(M+3H)/3 664.2493 664.2669 0.0176 5.41 ppm 
(M+4H)/4 498.4389 498.4535 0.0146 5.97 ppm 
     
   
Typical deviation of 
Waters LC/Q-TOF 
====> 10 ppm 
  
 
Figure 26:  HRMS of 7. 
  40
 
Figure 27:  HRMS of (M+2)/2 peak of 7. 
 
 
Figure 28:  HRMS of (M+3)/3 peak of 7. 
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Figure 29:  HRMS of (M+4)/4 peak of 7. 
 
 
Synthesis of 15 
Scaffold 15 was synthesized on a 25 mg scale on the Rink Amide AM (200-400 mesh) 
resin (0.63 mmol/g substitution).  The Fmoc protecting group was removed from the resin linker 
using general procedure C. 
Nα-Fmoc-Nγ-Boc-L-lysine (14.8 mg, 31.5 μmol) was coupled to the resin using general 
procedure A.  After capping using general procedure B and deprotection using general procedure 
C, these steps were repeated once more for this residue to give a total of 2 identical residues in a 
row.   
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Nα-Fmoc-Nγ-ivDde-L-diaminobutanoic acid (17.2 mg, 31.5 μmol) was coupled to the 
resin using the general procedure A, and the sequence was capped using general procedure B and 
deprotected using general procedure C. 
Nα-Fmoc-Nβ-Boc pro4(2S4S) was coupled to the resin using general procedure A.  After 
capping using general procedure B and deprotection using general procedure C, these steps were 
repeated seven more times for this residue, pro4(2S4S), to give a total of 8 identical residues in a 
row.   
Nα-Fmoc-Nγ-ivDde-L-diaminobutanoic acid (17.2 mg, 31.5 μmol) was coupled to the 
resin using general procedure A and capped using general procedure B.  The deprotection step 
(general procedure C) was performed for a total of 2 h to allow for complete diketopiperazine 
formation.  The capping step was then repeated, followed by a deprotection of the N-ivDde 
protecting groups using 2% hydrazine in DMF, 10 × 1 mL under argon bubbling.  The resin was 
then washed with 2 mL each of DMF, i-PrOH, DMF, i-PrOH, and DMF for 2 min each under 
argon bubbling.   
5-Carboxymethyl-8-hydroxyquinoline (16.0 mg, 78.8 μmol) was coupled using general 
procedure A, however using 5 equiv acid, 4.8 equiv HATU, 10 equiv DIPEA, 0.2 M in 20% 
DCM/DMF.  The resin was washed with 1 mL of 20% piperidine/DMF under argon bubbling to 
break up any 8-hydroxyquinoline phenyl ester polymeric chains that had formed on the resin.  
This coupling and washing step was repeated three additional times.  The resin was then 
prepared for cleavage by washing with 2 mL each of DMF, i-PrOH, DMF, i-PrOH, DCM, 
MeOH, DCM, MeOH, and DCM for 2 min.  The reactor was then put in a vacuum tube, and 
dried under reduced pressure overnight.   
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A small stir bar was added to the solid phase reaction vessel, which was then capped.  
Water (12.5 μL) and triisopropylsilane (12.5 μL) were added followed by TFA (475 μL).  The 
cleavage solution was stirred for 2 h and then filtered dropwise into a 1.5 mL microcentrifuge 
tube.  The resin was washed with TFA, which was filtered into the microcentrifuge tube as well.  
The resulting solution was blown dry under nitrogen.  This residue was then dissolved in 20% 
piperidine/NMP (2 mL) and sealed in an HPLC vial for 36 h with diketopiperazine closure 
monitored by LCMS.  This solution was then added dropwise to ether, and the precipitate was 
pelleted by centrifugation.  The product was purified by preparative HPLC (mobile phase, 
MeCN (0.05% formic acid) / H2O (0.1% formic acid), 0% to 50% MeCN over 30 min; flow rate 
25 mL/min).  Desired fractions were concentrated by lyophilization to give a fluffy light yellow 
solid.  The expected mass of 15 was confirmed by HPLC-MS, illustrated in Figure 30 and Figure 
31. 
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Figure 30:  HPLC chromatogram of 15: mobile phase, H2O (0.1% formic acid) / CH3CN, 5% to 50% 
CH3CN over 30 min; flow rate, 0.80 mL/min; UV detection at 252 nm; tR for 15, 10.2 min. 
 
 
Figure 31:  Mass trace of 15; ESI-MS m/z (ion) 974.8 (M + 2H+)/2, 650.2 (M + 3H+)/3, 488.0 (M + 4H+)/4. 
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